medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 2

<< Back Next >>

Med Int Mex 2016; 32 (2)

Seborrheic dermatitis and Malassezia. Relation in patients with diabetes mellitus type 2

Tello-Ibáñez OO, Fabián-San Miguel G, Arenas R, Guevara-Cervantes JF, Fernández R
Full text How to cite this article

Language: Spanish
References: 22
Page: 185-189
PDF size: 597.15 Kb.


Key words:

diabetes mellitus type 2, Malassezia, seborrheic dermatitis.

ABSTRACT

Background: Seborrheic dermatitis and the presence of Malassezia are frequently observed in immunocompromised patients. No relation- descamaship has been established between the two events in patients with type 2 diabetes mellitus.
Objetive: To determine whether a relationship exists between Malassezia and seborrheic dermatitis in individuals with type 2 diabetes mellitus, and to identify the frequency of the presence of yeast and dermatitis in these patients.
Material and Method: An open, prospective, observational, descriptive and cross-sectional study was done in volunteer subjects who participated in the 22nd National Stroke Patient with Diabetes in Mexico City on October 18, 2014; a clinical search for seborrheic dermatitis and investigation of Malassezia by a Gram-stained smears of skin was done. The relationship between them was determined with χ2 test.
Results: 118 patients were included, 84 had seborrheic dermatitis (72%), and 49 (42%) Malassezia. There was no statistical relationship between the two groups.
Conclusion: In patients with diabetes mellitus type 2 frequency of seborrheic dermatitis was high, but the presence of Malassezia was not. There is not statistically significant between both.


REFERENCES

  1. Torres E, Arenas R, Atoche-Diéguez C. Infecciones causadas por el género Malassezia. Med Cutan Iber Lat Am 2008;36:265-284.

  2. Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002;15:21-57.

  3. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002;15:545-563.

  4. Padilla-Desgarennes MC. Pitiriasis versicolor. Dermatología Rev Mex 2005;49:157-167.

  5. Hernández-Hernández F. El género Malassezia y patologías asociadas. En Méndez-Tovar I, López-Martínez R, Hernández-Hernández F. Actualidades en Micología Médica. México: Fac Med UNAM, 2004:143-157.

  6. Crespo-Erchiga V, Delgado-Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis 2002;15:133-142.

  7. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012;25:106-141.

  8. Bergbrant IM. Seborrhoeic dermatitis and Pityrosporum yeasts. Curr Top Med Mycol 1995;6:95-112.

  9. Bergbrant IM, Faergemann J. The role of Pityrosporum ovale in seborrheic dermatitis. Semin Dermatol 1990;9:262-268.

  10. Daoud AK, Tayyar MA, Fouda IM, Harfeil NA. Effects of diabetes mellitus vs in vitro hyperglycemia on select immune cell functions. J Immunotoxicol 2009;6:36-41.

  11. Rincón S, Celis A, Sopó L, Motta A, Cepero de García MC. Malassezia yeast species isolated from patients with dermatologic lesions. Biomedica 2005;25:189-195.

  12. Lacy-Niebla RM, Guevara Sanginés E, De la Barreda-Becerril F, Arce Ramírez M, et al. Micosis superficiales en pacientes oncológicos. Estudio en 98 pacientes. Med Cutan Iber Lat Am 2007;35:83-88.

  13. Orozco-Topete R, Arenas R. Pytirosporum ovale en dermatitis seborreica. Estudio en 26 pacientes con SIDA y 21 controles. Dermatología Rev Mex 1995;39:343-346.

  14. Marín-Cora E, Domínguez-Cherit J, Arenas R. Dermatitis seborreica en Parkinson. Correlación clínico-micológica en 30 casos y revisión de la literatura. Dermatología Rev Mex 1992;37:228-234.

  15. Cabello I, Cermeño-Vivas JR. Foliculitis por malassezia spp en un paciente inmunocomprometido. Dermatología Venezolana 2004;42:18-20.

  16. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 3ª ed. México: McGraw-Hill Interamericana Editores, 2009;62-66.

  17. Bilgili ME, Yildiz H, Sarici G. Prevalence of skin diseases in a dermatology outpatient clinic in Turkey. A cross-sectional, retrospective study. J Dermatol Case Rep 2013;7:108-112.

  18. Bernier V, Weill FX, Hirigoyen V, Elleau C, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002;138:215-218.

  19. Kaur M, Narang T, Bala M, Gupte S, et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital. Punjab. Indian J Med Microbiol 2013;31:270-274.

  20. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-405.

  21. Gupta AK, Kohli Y. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med Mycol 2004;42:35-42.

  22. Mirza SH, RehmanHu, Khan MA. Role of Malassezia yeast (Pityrosporum) in seborrhoeic dermatitis (SD). J Coll Physicians Surg Pak 2005;15:771-773.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2016;32